InvestorsHub Logo
Followers 0
Posts 180
Boards Moderated 0
Alias Born 08/07/2016

Re: friendofthedevil post# 33381

Tuesday, 09/12/2017 8:43:28 PM

Tuesday, September 12, 2017 8:43:28 PM

Post# of 108192
Stendhal already has AXAL rights to South America. I believe they even made a payment for the AIM2CERV trial. But I agree with you that BMY might be the most probable partner for AXAL-DUAL. I am confident that if the backend royalties are just 10% for EU, China and Japan (Biocon has India rights), then ADXS will receive more than 100 million in upfront payment. We'll see how well they negotiate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News